Q: Hi folks, can please your expertise of Q1 results for Verano vrno/c...the results seemed to beat estimates...and appear to be place the company in Top Tier of US Cannabis stocks, with Trulieve, Green Thumb, Curaleaf. Hard for US Pot companies to make profit without SAFE Act & relief from 280 Tax....would you rate Verano Buy/Hold/Sell....thanks as always..jb Piedmont QC
Q: lots of copper being used currently, any info on the companies that turn the copper into wiring for vehicles , industrial and residential ? thanks. Alot of copper will be required unless it can be replaced by a substitute material. Any ideas for substitutes?
Q: Earlier you commented on the earnings saying that the market may not like their revenue miss from $35.4M from and expected $36.2M.
On the other hand, they bought a company as big as them. Since that deal closed on March 31, it was not accretive to the earnings released yesterday BUT they guided considerable higher on revenue and EBITDA for the year.
Wouldn't increasing the future guidance have more of and effect on the stock price than earnings of a quarter where the puchase was not accretive?
Thanks
Q: Hey there! I'm 29. I have my RRSPs maxed out in index funds, TFSA maxed out in more growth companies (many of your picks and US growth stocks). I'm about to sell my rental property and should have about $100,000 in cash to invest. Looking to grow the money as much as possible, and then turn it into an income source. Will be working for another 2-3 years in a high paying job and then will work part time and pursue other interests and live off my investments. Any ideas on how to invest these funds?
Q: Hi 5i,
After the reported, and it up 15% today. Is it still attractive price to buy at $80? Any suggestion for good price to start collecting. Many thanks.
Q: 2020 seemed pretty good as does Q1 2021. They are currently working to obtain debt financing for an expansion with a dfs planned for this summer.
What is your current view of Steppe and their future potential ?
Q: Please share your analysis of the recent results. Looks like most of the growth is driven by Handicare and very little or no organic growth. Please share your comments in organic vs. inorganic growth.
What are the future prospects after acquisition
Will dividends be maintained and what about dividend growth.
Will Savara be able to generate decent cash flow or will they have to resort to debt to manage new acquisition and future plans?